NCT03826771

Brief Summary

The investigators will study the effects of a 12 week strength training program on individuals who have had a stroke and are depressed to see if this type of exercise training helps treat depression and improves walking function. Our goal is to use the information collected in this study to help design treatments for people who have had a stroke that will help with many of the common consequences of stroke, including depression, muscle weakness and slow walking. Progress toward overcoming some of these issues would be incredibly valuable to any person who has had a stroke and their families.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
48

participants targeted

Target at P25-P50 for phase_2 stroke

Timeline
Completed

Started Feb 2019

Longer than P75 for phase_2 stroke

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 29, 2019

Completed
3 days until next milestone

First Posted

Study publicly available on registry

February 1, 2019

Completed
5 days until next milestone

Study Start

First participant enrolled

February 6, 2019

Completed
5.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 15, 2024

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 12, 2024

Completed
12 months until next milestone

Results Posted

Study results publicly available

April 24, 2025

Completed
Last Updated

April 24, 2025

Status Verified

April 1, 2025

Enrollment Period

5.1 years

First QC Date

January 29, 2019

Results QC Date

March 10, 2025

Last Update Submit

April 22, 2025

Conditions

Keywords

strokerehabilitationdepressionexercise

Outcome Measures

Primary Outcomes (1)

  • Change in Mean Score of Depression as Assessed by the Hamilton Rating Scale for Depression

    The HAM-D is a clinician-rated scale with scores based on clinical interview and family report. It addresses both somatic and psychological symptoms of depression. Items are rated on either a 5-point scale (0 to 4) or 3-point scale (0 to 2), where higher scores represent increasing severity of depression. The scores of the 17 items are summed to obtain a total score (minimum score: 0, maximum score: 52).

    Visit 1 through visit 24 (up to 12 weeks)

Secondary Outcomes (1)

  • Change in Self Selected Walking Speed

    Visit 1 through visit 24 (up to 12 weeks)

Study Arms (2)

POWER training

EXPERIMENTAL

high velocity strength training

Behavioral: Power training

Stretching

ACTIVE COMPARATOR

Upper and lower body range of motion exercises

Behavioral: Stretching

Interventions

Power trainingBEHAVIORAL

high-intensity lower extremity resistance training

POWER training
StretchingBEHAVIORAL

upper and lower body range of motion exercises

Stretching

Eligibility Criteria

Age50 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • age 50-70
  • stroke within the past 6 to 60 months
  • residual paresis in the lower extremity (Fugl-Meyer LE motor score \<34)
  • ability to walk without assistance and without an AFO during testing and training at speeds ranging from 0.2-0.8 m/s
  • no antidepressant medications or no change in doses of psychotropic medication for at least 4 weeks prior to the study (6 weeks if newly initiated medication)
  • HRSD question #9 regarding suicide \<2; and 7) provision of informed consent.

You may not qualify if:

  • Unable to ambulate at least 150 feet prior to stroke, or experienced intermittent claudication while walking
  • history of congestive heart failure, unstable cardiac arrhythmias, hypertrophic cardiomyopathy, severe aortic stenosis, angina or dyspnea at rest or during ADL's
  • History of COPD or oxygen dependence
  • Preexisting neurological disorders, dementia or previous stroke
  • History of major head trauma
  • Legal blindness or severe visual impairment
  • history of psychosis or other Axis I disorder that is primary
  • Life expectancy \<1 yr.
  • Severe arthritis or other problems that limit passive ROM
  • History of DVT or pulmonary embolism within 6 months
  • Uncontrolled diabetes with recent weight loss, diabetic coma, or frequent insulin reactions
  • Severe hypertension with systolic \>200 mmHg and diastolic \>110 mmHg at rest
  • attempt of suicide in the last 2 years or at suicidal risk assessed by SCID interview
  • History of seizures or currently prescribed anti-seizure medications
  • Current enrollment in a clinical trial to enhance motor recovery
  • +1 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Medical University of South Carolina

Charleston, South Carolina, 29425, United States

Location

MeSH Terms

Conditions

StrokeDepressionMotor Activity

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular DiseasesBehavioral SymptomsBehavior

Results Point of Contact

Title
Chris Gregory
Organization
Medical University of South Carolina

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 29, 2019

First Posted

February 1, 2019

Study Start

February 6, 2019

Primary Completion

March 15, 2024

Study Completion

May 12, 2024

Last Updated

April 24, 2025

Results First Posted

April 24, 2025

Record last verified: 2025-04

Locations